AAAAAA

   
Results: 1-8 |
Results: 8
ORAL CAVITY COMPLICATIONS OF BONE-MARROW TRANSPLANTATION
Authors: EISEN D ESSELL J BROUN ER
Citation: D. Eisen et al., ORAL CAVITY COMPLICATIONS OF BONE-MARROW TRANSPLANTATION, Seminars in cutaneous medicine and surgery, 16(4), 1997, pp. 265-272
PILOT TRIAL OF AN ORAL TWICE-DAILY NEW L-VALYL ESTER OF ACYCLOVIR (VALACYCLOVIR) FOR PROPHYLAXIS AGAINST HERPES-SIMPLEX VIRUS (HSV) IN BONE-MARROW TRANSPLANT PERIPHERAL STEM-CELL (BMT) PATIENTS
Authors: ESSELL J BROUN ER SIGMUND D TIERNEY K DEVOE M EISEN D
Citation: J. Essell et al., PILOT TRIAL OF AN ORAL TWICE-DAILY NEW L-VALYL ESTER OF ACYCLOVIR (VALACYCLOVIR) FOR PROPHYLAXIS AGAINST HERPES-SIMPLEX VIRUS (HSV) IN BONE-MARROW TRANSPLANT PERIPHERAL STEM-CELL (BMT) PATIENTS, Blood, 90(10), 1997, pp. 2421-2421
BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL
Authors: SCHROEDER M JASLOWSKI A THOMAS A WARREN T LEWIS S ESSELL J HARMAN G ALLERTON J WILKS S OSSWALD M HALVORSON R
Citation: M. Schroeder et al., BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL, Blood, 88(10), 1996, pp. 3762-3762
BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS
Authors: RAYBON K THOMAS A SCHROEDER M LEWIS S CHRISTMAN K WILKS S OSSWALD M ABBOTT K HALVORSON R ESSELL J ALLERTON J
Citation: K. Raybon et al., BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS, Blood, 86(10), 1995, pp. 3833-3833
SONOGRAPHIC FINDINGS IN PATIENTS WITH HEPATIC VENOOCCLUSIVE DISEASE
Authors: TURNER D SCHROEDER M ESSELL J ALLERTON J
Citation: D. Turner et al., SONOGRAPHIC FINDINGS IN PATIENTS WITH HEPATIC VENOOCCLUSIVE DISEASE, Blood, 86(10), 1995, pp. 3867-3867
A RANDOMIZED DOUBLE-BLIND TRIAL OF PROPHYLACTIC URSODEOXYCHOLIC ACID (UDCA) VS PLACEBO TO PREVENT VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: ESSELL J SCHROEDER M THOMPSON J HARMAN G HALVORSON R CALLANDER N
Citation: J. Essell et al., A RANDOMIZED DOUBLE-BLIND TRIAL OF PROPHYLACTIC URSODEOXYCHOLIC ACID (UDCA) VS PLACEBO TO PREVENT VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 84(10), 1994, pp. 10000250-10000250
DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SCHROEDER M ESSELL J HARMAN G HALVORSON R DOLAN M CALLANDER N SNYDER M WILKS S ALLERTON J THOMPSON J
Citation: M. Schroeder et al., DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000425-10000425
DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD)
Authors: WILKS S ESSELL J MCGLASSON D HARMAN G HALVORSON R CALLANDER N SNYDER M ALLERTON J
Citation: S. Wilks et al., DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD), Blood, 82(10), 1993, pp. 10000623-10000623
Risultati: 1-8 |